Trimegestone is a progestin used in hormone replacement therapy (HRT) for postmenopausal women to treat symptoms like hot flashes and prevent osteoporosis, and in some contraceptive formulations. It is prescribed to counteract the effects of estrogen on the uterine lining, offering endometrial protection. It acts by binding to progesterone receptors to mimic the effects of progesterone, a key hormone in the menstrual cycle and pregnancy. It is grouped under the following drug class(es): Progestins. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Ondeva, 21-hydroxypromegestone and trimegestonum. Its PubChem CID is 68926.
Trimegestone
| CAS No | 74513-62-5 |
|---|---|
| Molecular Formula | C22H30O3 |
| Molecular Weight | 342.5 g/mol |
| Synonyms | (8S,13S,14S,17S)-17-[(2S)-2-hydroxypropanoyl]-13,17-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Trimegestone is a progestin used in hormone replacement therapy (HRT) for postmenopausal women to treat symptoms like hot flashes and prevent osteoporosis, and in some contraceptive formulations.
The listed CAS number is 74513-62-5.
The listed molecular formula is C22H30O3.
The listed molecular weight is 342.5 g/mol.
(8S,13S,14S,17S)-17-[(2S)-2-hydroxypropanoyl]-13,17-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one.
The source lists Ondeva, 21-hydroxypromegestone and trimegestonum.